GISSi 2; the beginning of the end or the end of the beginning for tissue plasminogen activator in acute myocardial infarct?
Verheugt, F.W.
Nederlands Tijdschrift Voor Geneeskunde 134(35): 1711-1712
1990
ISSN/ISBN: 0028-2162 PMID: 2120596 Document Number: 348862
Document emailed within 1 workday
Related Documents
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685Wang, S.P.; Liu, C.P.; Charng, M.J.; Chou, C.Y.; Tsai, J.H.; Pan, J.P.; Shyong, W.C.; Chan, W.L.; Kong, C.W.; Chang, M.S. 1989: The efficacy and safety of recombinant tissue plasminogen activator infusion in acute myocardial infarction Zhonghua Yi Xue Za Zhi 43(4): 223-228
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Barbash, G.I.; White, H.D.; Modan, M.; Diaz, R.; Hampton, J.R.; Heikkila, J.; Kristinsson, A.; Moulopoulos, S.; Paolasso, E.A.; Van der Werf, T. 1995: Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial European Heart Journal 16(3): 313-316
Gol'dberg, G.A.; Stepanov, M.A.; Panova, A.G. 1976: Importance of an early beginning of physical rehabilitation of patients with uncomplicated myocardial infarct Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 81-82
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Cannon, C.P.; Gibson, C.M.; McCabe, C.H.; Adgey, A.A.; Schweiger, M.J.; Sequeira, R.F.; Grollier, G.; Giugliano, R.P.; Frey, M.; Mueller, H.S.; Steingart, R.M.; Weaver, W.D.; Van de Werf, F.; Braunwald, E. 1998: TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators Circulation 98(25): 2805-2814
Tsukahara, K.; Kimura, K.; Usui, T.; Okuda, J.; Kitamura, Y.; Kosuge, M.; Sano, T.; Tohyama, S.; Nemoto, T.; Yamanaka, O.; Yoshii, Y.; Tochikubo, O.; Umemura, S. 2001: Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction Journal of Cardiology 37(3): 143-150
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60
Ol'binskaia, L.I.; Petrosian, I.R.; Gofman, A.M. 1989: The pharmacokinetics and the concentration-and-effect relationship of prazosin in patients at the beginning of the subacute period of myocardial infarct complicated by the development of heart failure Farmakologiia i Toksikologiia 52(5): 68-72
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Colman, I.; Jones, P.B. 2004: Birth cohort studies in psychiatry: beginning at the beginning Psychological Medicine 34(8): 1375-1383
Pheerawong, P.; Plienthaisong, B. 2014: Outcome of recombinant tissue plasminogen activator in ST-segment elevation myocardial infarction in Buriram Hospital Journal of the Medical Association of Thailand 97(8): 804-811
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Neurosciences 7(1): 7-13
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Saudi Medical Journal 23(1): 13-19